Natixis’s Histogen Inc. Common Stock HSTO Stock Holding History

Natixis’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,990	Closed	-$60K	–	1399
2021 Q3	$60K	Sell	3,990 -455	-10%	-$7.7K	﹤0.01%	1172
2021 Q2	$97K	Buy	+4,445	New	+$92.2K	﹤0.01%	832

Other funds holding HSTO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Natixis's HSTO Position: Q4 2021 in Review

Natixis sold out of Histogen Inc. Common Stock (HSTO) in Q4 2021, closing a stake of 3,990 shares — an estimated $60K sold.

Natixis first reported a position in HSTO in Q2 2021 and held it in 2 quarters. The position peaked at $97K in Q2 2021. 24 funds tracked by Wall St. Rank hold HSTO as of Q4 2021.

Natixis reported no remaining Histogen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Natixis sold 3,990 Histogen Inc. Common Stock shares in Q4 2021, an estimated $60K.
Natixis first reported a position in Histogen Inc. Common Stock in Q2 2021 and held it in 2 quarters.
Natixis's Histogen Inc. Common Stock position peaked at $97K in Q2 2021.
24 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2021.

Based on Natixis's 13F filing for Q4 2021, filed 14 Feb 2022.